berotek has been researched along with Hyaline Membrane Disease in 2 studies
Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.
Hyaline Membrane Disease: A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gunston, KD | 1 |
| Davey, DA | 1 |
| Zsolnai, B | 1 |
| Gyévai, A | 1 |
| Pucsok, J | 1 |
1 trial available for berotek and Hyaline Membrane Disease
| Article | Year |
|---|---|
Effects of prenatal fenoterol, phenobarbitone and dexamethasone administration on the total phospholipid content of amniotic fluid.
Topics: Amniotic Fluid; Clinical Trials as Topic; Dexamethasone; Ethanolamines; Female; Fenoterol; Humans; H | 1978 |
1 other study available for berotek and Hyaline Membrane Disease
| Article | Year |
|---|---|
Lung maturation and prevention of hyaline membrane disease.
Topics: Ambroxol; Dexamethasone; Fenoterol; Humans; Hyaline Membrane Disease; Infant, Newborn; Lung; Organ C | 1985 |